1. Home
  2. CNTA vs LILAK Comparison

CNTA vs LILAK Comparison

Compare CNTA & LILAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • LILAK
  • Stock Information
  • Founded
  • CNTA 2020
  • LILAK 2017
  • Country
  • CNTA United Kingdom
  • LILAK Bermuda
  • Employees
  • CNTA N/A
  • LILAK N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • LILAK Cable & Other Pay Television Services
  • Sector
  • CNTA Health Care
  • LILAK Telecommunications
  • Exchange
  • CNTA Nasdaq
  • LILAK Nasdaq
  • Market Cap
  • CNTA 1.6B
  • LILAK 1.1B
  • IPO Year
  • CNTA 2021
  • LILAK N/A
  • Fundamental
  • Price
  • CNTA $14.29
  • LILAK $6.34
  • Analyst Decision
  • CNTA Strong Buy
  • LILAK Buy
  • Analyst Count
  • CNTA 10
  • LILAK 3
  • Target Price
  • CNTA $28.78
  • LILAK $10.27
  • AVG Volume (30 Days)
  • CNTA 980.2K
  • LILAK 1.2M
  • Earning Date
  • CNTA 08-12-2025
  • LILAK 08-05-2025
  • Dividend Yield
  • CNTA N/A
  • LILAK N/A
  • EPS Growth
  • CNTA N/A
  • LILAK N/A
  • EPS
  • CNTA N/A
  • LILAK N/A
  • Revenue
  • CNTA $15,000,000.00
  • LILAK $4,441,000,000.00
  • Revenue This Year
  • CNTA N/A
  • LILAK $2.45
  • Revenue Next Year
  • CNTA N/A
  • LILAK $3.11
  • P/E Ratio
  • CNTA N/A
  • LILAK N/A
  • Revenue Growth
  • CNTA 118.88
  • LILAK N/A
  • 52 Week Low
  • CNTA $9.00
  • LILAK $4.23
  • 52 Week High
  • CNTA $19.09
  • LILAK $10.93
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 61.38
  • LILAK 61.36
  • Support Level
  • CNTA $13.22
  • LILAK $5.92
  • Resistance Level
  • CNTA $14.74
  • LILAK $6.65
  • Average True Range (ATR)
  • CNTA 0.73
  • LILAK 0.31
  • MACD
  • CNTA 0.14
  • LILAK 0.01
  • Stochastic Oscillator
  • CNTA 85.11
  • LILAK 68.37

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

About LILAK Liberty Latin America Ltd. Class C

Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.

Share on Social Networks: